BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5515384)

  • 1. [The behaviour of the serum insulin level in non obese adult diabetics after intravenous glucose, tolbutamide and glucagon].
    Lawecki J; Rogala H; Czyzyk A; Kowalski H
    Acta Diabetol Lat; 1970; 7(3):407-20. PubMed ID: 5515384
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range.
    Kosaka K; Hagura R; Kuzuya T; Kuzuya N
    Diabetologia; 1974 Dec; 10(6):775-82. PubMed ID: 4442669
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of age on serum insulin level following intravenous administration of glucose, tolbutamide and glucagon].
    Sorge F; Passarge E; Neuhaus GA
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1393-6. PubMed ID: 347781
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tolbutamide and insulin on insulin inhibitory activity associated with plasma albumin.
    Devrim S; Kilo C; Voyles N; Recant L
    Diabetes; 1968 Dec; 17(12):746-51. PubMed ID: 5726254
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
    Chiba M; Ohneda A; Sakai T; Goto Y
    Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man.
    Goldsmith SJ; Yalow RS; Berson SA
    Diabetes; 1970 Jun; 19(6):453-7. PubMed ID: 4393032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
    Melani F; Lawecki J; Bartelt KM; Pfeiffer EF
    Diabetologia; 1967 Oct; 3(5):422-6. PubMed ID: 5620801
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute insulin response to glucagon, tolbutamide, and glucose in non-insulin-dependent diabetes of the young.
    Naidoo C; Jialal I; Suleman A; Rajput MC; Joubert SM
    Diabetes Care; 1986; 9(1):57-60. PubMed ID: 3512209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of tolbutamide-mediated insulin release in adult onset diabetics by methysergide maleate.
    Baldridge JA; Quickel KE; Feldman JM; Lebovitz HE
    Diabetes; 1974 Jan; 23(1):21-4. PubMed ID: 4588670
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.
    Perley M; Kipnis DM
    Diabetes; 1966 Dec; 15(12):867-74. PubMed ID: 5957477
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood glucose and serum insulin levels in children with cystic fibrosis.
    Milner AD
    Arch Dis Child; 1969 Jun; 44(235):351-5. PubMed ID: 4891523
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.
    Ryan WG; Nibbe AF; Schwartz TB
    Lancet; 1967 Jun; 1(7502):1255-6. PubMed ID: 4165041
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The insulinemic response after oral administration of glucose and after intravenous administration of tolbutamide in patients with Cushin's syndrome].
    Muggeo M; Tiengo A; Avogaro P; Crepaldi G; Enzi G; Trisotto A; Federspil G
    Acta Isot (Padova); 1967 Dec; 7(1):99-116. PubMed ID: 5612077
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagon and tolbutamide as insulin secretagogues in the pig (Sus domesticus).
    Richardson RI; Weekes TE
    Comp Biochem Physiol A Comp Physiol; 1982; 73(3):389-93. PubMed ID: 6128123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.